Clinical Trial

A Phase 4 Clinical Study to Investigate the Effectiveness and Safety of Skin Resurfacing

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study is a prospective, post-marketing (Phase 4) non-registrational single-arm, open-label, multicenter study.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2025-10-07; most recent amendment 2026-06-10.
Status change: Recruiting → Active, Not Recruiting 2026-02-11
Status change: Not Yet Recruiting → Recruiting 2025-10-24
Trial Details
NCT Number NCT07214272
Lead Sponsor Bausch Health Americas, Inc.
Conditions Skin Resurfacing
Enrollment 49 participants
Start Date 2025-10-17
Primary Completion 2026-05-20 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2026-06-11